A Study of the Effects of Canagliflozin on Plasma Volume in Patients With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the effects of canagliflozin on plasma volume and
renal parameters in patients with Type 2 Diabetes Mellitus who are currently taking metformin
and being treated for high blood pressure.